OYLER JOHN 4
4 · BeOne Medicines Ltd. · Filed Jul 22, 2026
Research Summary
AI-generated summary of this filing
BeOne (ONC) CEO John Oyler Exercises Options and Sells Shares
What Happened
John Oyler, CEO of BeOne Medicines Ltd. (ONC), exercised stock derivative(s) and conducted a series of open-market sales on July 20–21, 2026. The filing shows he acquired 33,990 shares by exercising options at $119.96 per share (cost ≈ $4,077,440) and sold a total of 109,713 shares in multiple open‑market transactions at prices around $310–$320, producing aggregate proceeds of about $34.59 million. The filing also reports a separate derivative/convertive disposition of 441,870 shares showing $0 proceeds (reported as a derivative transaction).
Key Details
- Transaction dates: primarily July 20–21, 2026; Form 4 filed July 22, 2026 (timely filing).
- Option exercise: 33,990 shares acquired at $119.96 each (≈ $4,077,440).
- Open-market sales: 109,713 shares sold in multiple blocks; weighted-average prices reported per block; total proceeds ≈ $34.59M.
- Derivative disposition: 441,870 shares reported as disposed at $0 (no cash reported).
- Notable footnotes: sales covered by a Rule 10b5‑1 trading plan (footnote F7); several sales reported as weighted-average prices spanning listed price ranges (footnotes F8–F21); each American Depositary Share (ADS) represents 13 ordinary shares (F6).
- Ownership disclaimers: some securities are held in trusts/LLCs for which Oyler disclaims beneficial ownership (footnotes F1–F5).
- Shares owned after these transactions: not specified in the provided excerpt of the filing.
Context
- The filing shows an exercise of options followed by immediate open‑market sales on the same days, which effectively converted optioned shares into cash; the separate $0 derivative disposition indicates a non‑cash settlement or internal conversion reported by the filer (the filing does not explain the mechanics).
- Sales under a 10b5‑1 plan are pre‑arranged and are commonly used to avoid questions about timing; the filing discloses this for at least some of the sales.
- This is factual reporting of transactions only — it does not indicate the CEO’s reasons or signal company performance by itself.
Insider Transaction Report
Form 4
OYLER JOHN
DirectorChief Executive Officer
Transactions
- Sale
American Depositary Shares
[F6][F7][F8]2026-07-20$310.08/sh−5,146$1,595,678→ 9,180 total - Sale
American Depositary Shares
[F6][F7][F9]2026-07-20$310.75/sh−6,273$1,949,310→ 2,907 total - Sale
American Depositary Shares
[F6][F7][F10]2026-07-20$311.80/sh−2,907$906,389→ 0 total - Exercise/Conversion
American Depositary Shares
[F6]2026-07-20$119.96/sh+33,990$4,077,440→ 33,990 total - Sale
American Depositary Shares
[F6][F7][F11]2026-07-20$312.29/sh−15,499$4,840,115→ 18,491 total - Sale
American Depositary Shares
[F6][F7][F12]2026-07-20$312.96/sh−14,326$4,483,433→ 4,165 total - Sale
American Depositary Shares
[F6][F7][F13]2026-07-20$313.91/sh−1,850$580,732→ 2,315 total - Sale
American Depositary Shares
[F6][F7][F14]2026-07-20$315.26/sh−1,512$476,678→ 803 total - Sale
American Depositary Shares
[F6][F7][F15]2026-07-20$316.14/sh−523$165,339→ 280 total - Sale
American Depositary Shares
[F6][F7]2026-07-20$318.30/sh−280$89,124→ 0 total - Sale
American Depositary Shares
[F6][F7][F16]2026-07-21$316.26/sh−15,379$4,863,766→ 46,018 total - Sale
American Depositary Shares
[F6][F7][F17]2026-07-21$316.91/sh−20,029$6,347,340→ 25,989 total - Sale
American Depositary Shares
[F6][F7][F18]2026-07-21$318.41/sh−7,842$2,496,997→ 18,147 total - Sale
American Depositary Shares
[F6][F7][F19]2026-07-21$319.29/sh−15,807$5,047,019→ 2,340 total - Sale
American Depositary Shares
[F6][F7][F20]2026-07-21$320.06/sh−2,340$748,936→ 0 total - Exercise/Conversion
Share Option (Right to Buy)
[F21][F22]2026-07-20−441,870→ 0 totalExercise: $9.23Exp: 2029-06-04→ Ordinary Shares (441,870 underlying)
Holdings
- 4,461,518
Ordinary Shares
- 481,533(indirect: See Footnote)
Ordinary Shares
[F1] - 7,699,158(indirect: See Footnote)
Ordinary Shares
[F2] - 28,204,115(indirect: See Footnote)
Ordinary Shares
[F3] - 9,545,000(indirect: See Footnote)
Ordinary Shares
[F4] - 102,188(indirect: See Footnote)
Ordinary Shares
[F5]
Footnotes (22)
- [F1]These securities are held by the P&O Trust, the beneficiaries of which include the Reporting Person's child and others, for which the Reporting Person disclaims beneficial ownership.
- [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $311.46 to $311.98, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- [F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $311.98 to $312.45, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- [F12]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $312.46 to $313.39, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- [F13]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $313.47 to $314.36, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- [F14]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $314.74 to $315.60, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- [F15]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $315.91 to $316.33, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- [F16]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $315.67 to $316.66, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- [F17]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.67 to $317.62, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- [F18]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.72 to $318.685, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- [F19]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.79 to $319.78, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- [F2]These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
- [F20]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $319.82 to $320.39, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- [F21]The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.
- [F22]These securities vest over a four-year period as follows: 25% on June 5, 2020, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon a change in control or certain termination events.
- [F3]These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interests are owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
- [F4]These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account.
- [F5]These securities are held by The John Oyler Legacy Trust for the benefit of the Reporting Person's child, for which the Reporting Person disclaims beneficial ownership.
- [F6]Each American Depositary Share represents 13 Ordinary Shares.
- [F7]The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2026.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $309.39 to $310.38, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $310.39 to $311.36, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
Signature
/s/ Frank Collazo, as Attorney-in-Fact|2026-07-22